1. Home
  2. LPA vs HURA Comparison

LPA vs HURA Comparison

Compare LPA & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPA
  • HURA
  • Stock Information
  • Founded
  • LPA 2013
  • HURA 2009
  • Country
  • LPA United States
  • HURA United States
  • Employees
  • LPA N/A
  • HURA N/A
  • Industry
  • LPA
  • HURA
  • Sector
  • LPA
  • HURA
  • Exchange
  • LPA Nasdaq
  • HURA Nasdaq
  • Market Cap
  • LPA 211.9M
  • HURA 171.7M
  • IPO Year
  • LPA N/A
  • HURA N/A
  • Fundamental
  • Price
  • LPA $8.16
  • HURA $2.93
  • Analyst Decision
  • LPA
  • HURA Strong Buy
  • Analyst Count
  • LPA 0
  • HURA 2
  • Target Price
  • LPA N/A
  • HURA $11.50
  • AVG Volume (30 Days)
  • LPA 44.9K
  • HURA 111.4K
  • Earning Date
  • LPA 05-14-2025
  • HURA 05-15-2025
  • Dividend Yield
  • LPA N/A
  • HURA N/A
  • EPS Growth
  • LPA N/A
  • HURA N/A
  • EPS
  • LPA 0.57
  • HURA N/A
  • Revenue
  • LPA $45,218,701.00
  • HURA N/A
  • Revenue This Year
  • LPA N/A
  • HURA N/A
  • Revenue Next Year
  • LPA N/A
  • HURA $69.15
  • P/E Ratio
  • LPA $14.61
  • HURA N/A
  • Revenue Growth
  • LPA 7.03
  • HURA N/A
  • 52 Week Low
  • LPA $5.90
  • HURA $1.80
  • 52 Week High
  • LPA $410.27
  • HURA $13.13
  • Technical
  • Relative Strength Index (RSI)
  • LPA N/A
  • HURA N/A
  • Support Level
  • LPA N/A
  • HURA N/A
  • Resistance Level
  • LPA N/A
  • HURA N/A
  • Average True Range (ATR)
  • LPA 0.00
  • HURA 0.00
  • MACD
  • LPA 0.00
  • HURA 0.00
  • Stochastic Oscillator
  • LPA 0.00
  • HURA 0.00

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: